NJIT -Vivek-Kumar (IMAGE)

New Jersey Institute of Technology

NJIT -Vivek-Kumar

Caption

With researchers in his lab, biomedical engineer Vivek Kumar developed a hydrogel therapy that in early tests prevented SARS-Cov-2 from infecting cells without targeting specific receptors on the spike.

Credit

NJIT

Usage Restrictions

None

License

Original content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.